Marco de MorpurgoPartner, Global Co-Chair of the Life Sciences Sector at DLA Piper
Marco de Morpurgo heads DLA Piper's EU Life Sciences regulatory practice and serves Global Co-Chair of the firm's Life Sciences Sector. His practice focuses on EU and national regulation of pharmaceuticals, biotechnologies, medical devices, and other health-related regulated products. He provides strategic and compliance advice on a broad range of regulatory issues, including clinical trials, product approvals, market access, distribution, promotion and advertising, post-market obligations, as well as on industry-specific ethical and behavioural rules. Most of Marco's work is multi-jurisdictional and he has broad experience assisting clients manage regulatory divergence within the EU and globally. Marco holds and LL.M. from Harvard Law School and a Ph.D. from the University of Milan. He is qualified in Italy, France, Spain, and New York. He teaches Life Sciences Law at HEC Paris and is a member of the Editorial Board of the European Pharmaceutical Law Review.